Table of Contents
What does BCG company do?
BCG India’s client work encompasses the spectrum of challenges facing today’s business leaders in a variety of industries, including: financial services, health care, industrial goods, consumer goods, technology, energy and utilities, and infrastructure and engineering, as well as government and non-profit …
What is special about BCG?
BCG has functional expertise, but it also boasts creative problem solving by offering its clients a fresh and unique framework with every case. It pushes consultants to think outside the box and to avoid fitting one client’s solutions to another client’s problems.
Is it worth working for BCG?
BCG is truly a great place to work IF you can accept the fact that work will consume most of your day during the week. The people are smart and caring, I’ve had plenty of interesting projects and opportunities to learn and grow professionally. Excellent health insurance.
What is it really like to work at BCG?
People at BCG are nice. They genuinely care about one another. That’s something that’s very important to BCG, and they work to bring people on that will advance that culture, and also people that will maintain it when they’re inside the firm – it’s a really exciting part of working at BCG.
What is the full form of BCG vaccination?
BCG, or bacille Calmette-Guerin, is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated.
What does analyst at BCG do?
As a Knowledge Analyst (KA) within BCG’s People & Organization Practice Area, you will work in a growing global team, providing functional expertise and insights, working together with BCG case and proposal teams to deliver customized knowledge assets and expert advisory.
How much does a partner at BCG makes in India?
Average BCG Partner salary in India is ₹ 105.3 Lakhs for employees with less than 1 year of experience. Partner salary at BCG ranges between ₹ 60 Lakhs to ₹ 150 Lakhs.
Why is BCG vaccine not used in the US?
However, BCG is not generally recommended for use in the United States because of the low risk of infection with Mycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccine’s potential interference with tuberculin skin test reactivity.